Melatonin: An Option for Improving Sleep in Children with Autism Spectrum Disorder (ASD)
Previous posts discussed sleep problems in children and strategies for improving their sleep. If the non-medication strategies in the previous post don't work, other options are available that are relatively risk free. Studies support the use of melatonin to reduce the time it takes for children with ASD to fall asleep (1, 2). Some studies suggest that melatonin increases total sleep time as well (2). Get more details about two scientific papers about melatonin use with children with autism below. Check with your child's doctor before starting melatonin to see if there are any reasons why you should avoid it.
Conduct a Melatonin Study with Your Child Yourself
We recommend that you follow steps similar to these studies when you give your child melatonin.
1. Parents were given a sleep diary to keep track of their children's sleep patterns. They started entering data before the melatonin was given. You can use SymTrendSleep for that purpose. Record the time your child went to bed and fell asleep. Record the number of times awakened during the night. Record the time your child got up in the morning and how sleepy he/she is. If you have time, also jot down what happened before bedtime that might have made falling asleep more difficult (such as activities or food).
2. The Vanderbilt senior researcher then trained parents to establish a regular bedtime and wake time. You should follow the recommendations in the previous post for doing that.
3. Start with a small dose of melatonin – 1 mg. A satisfactory response was defined in the research as falling asleep within 30 minutes in five or more nights/week for 3 weeks. If that response did not occur, the melatonin was increased to 3 mg for 3 weeks.
4. Jot down anything unusual that occurs after your child starts taking melatonin – possible side effects of the supplement. Most studies find melatonin is tolerated well. If you think something has changed for the worse, discontinue the melatonin and see if it changes back. Consult a professional.
Research on Melatonin
Researchers at Vanderbilt University published a study in 2012 (1) in which 24 children with autism who had sleep problems were given melatonin. This study found that supplemental melatonin improved the time to get to sleep in most children at 1 or 3 mg dosages. "It was effective in week 1 of treatment, maintained effects over several months, was well tolerated and safe, and showed improvements in sleep, behavior, and parenting stress." On average it took 20 minutes less for the child to go to sleep. Total sleep time did not significantly improve and the number of times the child woke up did not change. Parents completed a side effect checklist for review each week (1, 3) that includes such items as dizziness, diarrhea, speech difficulties, headache, loss of appetite, decreased concentration, slowness, hyperactivity, and behavior disturbances. Only one of 24 children exhibited mild diarrhea; all others tolerated the melatonin without difficulty.
Rossignol and Frye (2) reviewed well-controlled studies of melatonin use with children with autism. Their analysis of the literature showed significant improvements in sleep. Studies demonstrated the largest impact of melatonin on the time to get to sleep. They also found large differences in sleep duration. The time to fall asleep was 66 minutes shorter than baseline on average among those taking melatonin and 39 minutes shorter than those who took a placebo. Sleep duration was 73 minutes longer than baseline on average among those who took melatonin and 44 minutes longer than those who took a placebo.
1. Malow, B., Adkins, K.W., McGrew, S.G., Wang, L., Goldman, S.E., Fawkes, D. Burnette, C. Melatonin for Sleep in Children with Autism: A Controlled Trial Examining Dose, Tolerability, and Outcomes. J. Autism Developmental Disorders (2012) 42(8): 1729-37.
2. Rossignol, D.A. and Frye, R.E. Melatonin in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. Developmental Medicine and Child Neurology (2011) 53 (9), 783-792.
3. Carpay, J.A., Arts, W.F.M., Vermeulen, J., Stroink, H., Brouwer, O.F., Peters, A.C.B, vanDonselaar, C.A., Aldenkamp, A.P. Parent-completed Scales for Measuring Seizure Severity and Severity of Side-Effects of Antiepileptic Drugs in Childhood Epilepsy: Development and Psychometric Analysis. Epilepsy Research (1996) 24:173-181.